Delta-Fly Pharma, Inc. 4598.T
4598.T
Delta-Fly Pharma, Inc. 206A.T
PRISM BioLab Co.,LTD 4576.T
D. Western Therapeutics Institute, Inc. 4564.T
OncoTherapy Science, Inc. 4881.T
FunPep Company Limited 4572.T
Carna Biosciences, Inc. 2385.T
Soiken Holdings Inc. 4596.T
Kubota Pharmaceutical Holdings Co., Ltd. 4591.T
Ribomic Inc. 4594.T
BrightPath Biotherapeutics Co., Ltd.
Delta-Fly Pharma, Inc. 206A.T
PRISM BioLab Co.,LTD 4576.T
D. Western Therapeutics Institute, Inc. 4564.T
OncoTherapy Science, Inc. 4881.T
FunPep Company Limited 4572.T
Carna Biosciences, Inc. 2385.T
Soiken Holdings Inc. 4596.T
Kubota Pharmaceutical Holdings Co., Ltd. 4591.T
Ribomic Inc. 4594.T
BrightPath Biotherapeutics Co., Ltd.
Performance
| Periode | 4598.T | 206A.T | 4576.T | 4564.T | 4881.T | 4572.T | 2385.T | 4596.T | 4591.T | 4594.T |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 2.62 % | -34.41 % | -7.89 % | -8.33 % | 3.92 % | -18.43 % | 42.75 % | 40.00 % | 2.25 % | 77.78 % |
| YTD | -8.45 % | -47.57 % | -41.01 % | -8.33 % | -22.06 % | -28.52 % | 57.14 % | 26.00 % | 7.06 % | 45.45 % |
| 1Y | -4.68 % | -54.75 % | 50.00 % | -35.29 % | -19.08 % | -38.82 % | 34.53 % | 0.00 % | 16.67 % | 36.17 % |
| 3Y | -15.45 % | -71.53 % | -65.12 % | -63.93 % | -40.45 % | -76.63 % | -49.60 % | -49.60 % | -43.83 % | 3.23 % |
| 5Y | -15.45 % | -71.53 % | -70.83 % | -85.99 % | -86.41 % | -85.42 % | -80.54 % | -78.20 % | -79.08 % | -73.55 % |
| 10Y | -15.45 % | -71.53 % | -83.75 % | -92.99 % | -86.41 % | -90.60 % | -1.58 % | -93.94 % | -91.81 % | -84.62 % |
| From the beginning | -15.45 % | -71.53 % | -73.42 % | -95.32 % | -86.41 % | -80.00 % | -94.16 % | -93.94 % | -95.22 % | -84.62 % |